Memic Innovative Surgery announced that 2 Florida hospitals have completed the first procedures in the U.S. with the Hominis Surgical System.
The goal is standardized, quantifiable training on the Hominis surgical system.
Memic’s Hominis system will be used in single-site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures.
Memic develops Hominis, the first FDA-approved, robotically-assisted surgical device for performing transvaginal hysterectomy.
Memic develops Hominis, the first FDA approved, robotically-assisted surgical device for transvaginal hysterectomies.
Memic Innovative Surgery closed a $96 million Series D financing round. The Tel Aviv, Israel-based company develops Hominis, the first FDA-approved robotically-assisted surgical device for performing transvaginal hysterectomy. The FDA approved the Hominis system last month. Hominis is designed to remove the uterus using minimally invasive surgical instruments inserted through the vagina, as well as…